Evidence from past epidemics and preclinical research suggests that the COVID-19 pandemic may have a long-lasting impact on the pandemic of Parkinson’s disease, say scientists.
Evidence from past epidemics and preclinical research suggests that the COVID-19 pandemic may have a long-lasting impact on the pandemic of Parkinson’s disease, say scientists.